These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 7487558)

  • 1. Scapuloperoneal syndromes. Absence of linkage to the 4q35 FSHD locus.
    Tawil R; Myers GJ; Weiffenbach B; Griggs RC
    Arch Neurol; 1995 Nov; 52(11):1069-72. PubMed ID: 7487558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FSH dystrophy 4q35 deletion in patients presenting with facial-sparing scapular myopathy.
    Felice KJ; North WA; Moore SA; Mathews KD
    Neurology; 2000 May; 54(10):1927-31. PubMed ID: 10822431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A large New England kindred with autosomal dominant neurogenic scapuloperoneal amyotrophy with unique features.
    DeLong R; Siddique T
    Arch Neurol; 1992 Sep; 49(9):905-8. PubMed ID: 1520078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linkage of scapuloperoneal spinal muscular atrophy to chromosome 12q24.1-q24.31.
    Isozumi K; DeLong R; Kaplan J; Deng HX; Iqbal Z; Hung WY; Wilhelmsen KC; Hentati A; Pericak-Vance MA; Siddique T
    Hum Mol Genet; 1996 Sep; 5(9):1377-82. PubMed ID: 8872481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The FSHD-linked locus D4F104S1 (p13E-11) on 4q35 has a homologue on 10qter.
    Bakker E; Wijmenga C; Vossen RH; Padberg GW; Hewitt J; van der Wielen M; Rasmussen K; Frants RR
    Muscle Nerve Suppl; 1995; 2():S39-44. PubMed ID: 7739624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosome 12-linked autosomal dominant scapuloperoneal muscular dystrophy.
    Wilhelmsen KC; Blake DM; Lynch T; Mabutas J; De Vera M; Neystat M; Bernstein M; Hirano M; Gilliam TC; Murphy PL; Sola MD; Bonilla E; Schotland DL; Hays AP; Rowland LP
    Ann Neurol; 1996 Apr; 39(4):507-20. PubMed ID: 8619529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic-genotypic correlation will assist genetic counseling in 4q35-facioscapulohumeral muscular dystrophy.
    Lunt PW; Jardine PE; Koch M; Maynard J; Osborn M; Williams M; Harper PS; Upadhyaya M
    Muscle Nerve Suppl; 1995; 2():S103-9. PubMed ID: 7739619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA rearrangements in Japanese facioscapulohumeral muscular dystrophy patients: clinical correlations.
    Goto K; Lee JH; Matsuda C; Hirabayashi K; Kojo T; Nakamura A; Mitsunaga Y; Furukawa T; Sahashi K; Arahata K
    Neuromuscul Disord; 1995 May; 5(3):201-8. PubMed ID: 7633185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FSHD-like patients without 4q35 deletion.
    Yamanaka G; Goto K; Ishihara T; Oya Y; Miyajima T; Hoshika A; Nishino I; Hayashi YK
    J Neurol Sci; 2004 Apr; 219(1-2):89-93. PubMed ID: 15050443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A family with facioscapulohumeral muscular dystrophy and hereditary long QT syndrome].
    Kimura T; Moriwaki T; Sawada J; Naka T; Hazama T; Nakata T
    Rinsho Shinkeigaku; 1997 Aug; 37(8):690-2. PubMed ID: 9404145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Facioscapulohumeral muscular dystrophy. The spectrum of clinical manifestations and molecular genetic changes].
    Krasnianski M; Neudecker S; Eger K; Schulte-Mattler W; Zierz S
    Nervenarzt; 2003 Feb; 74(2):151-8. PubMed ID: 12596016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetic analysis of facioscapulohumeral muscular dystrophy (FSHD)].
    Goto K; Song MD; Lee JH; Arahata K
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1416-8. PubMed ID: 8752415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurogenic scapuloperoneal syndrome in childhood.
    Mercelis R; Demeester J; Martin JJ
    J Neurol Neurosurg Psychiatry; 1980 Oct; 43(10):888-96. PubMed ID: 7441268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scapuloperoneal syndrome. Report on two families with neurogenic muscular atrophy.
    Sulaiman AR; McQuillen MP; Viste KM; Hughes CV
    J Neurol Sci; 1981; 52(2-3):305-25. PubMed ID: 7310437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical variability of facioscapulohumeral muscular dystrophy in Russia.
    Kazakov VM; Rudenko DI
    Muscle Nerve Suppl; 1995; 2():S85-95. PubMed ID: 7739632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between fragment size at D4F104S1 and age at onset or at wheelchair use, with a possible generational effect, accounts for much phenotypic variation in 4q35-facioscapulohumeral muscular dystrophy (FSHD).
    Lunt PW; Jardine PE; Koch MC; Maynard J; Osborn M; Williams M; Harper PS; Upadhyaya M
    Hum Mol Genet; 1995 May; 4(5):951-8. PubMed ID: 7633457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory response in facioscapulohumeral muscular dystrophy (FSHD): immunocytochemical and genetic analyses.
    Arahata K; Ishihara T; Fukunaga H; Orimo S; Lee JH; Goto K; Nonaka I
    Muscle Nerve Suppl; 1995; 2():S56-66. PubMed ID: 7739627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No evidence of genetic heterogeneity in Brazilian facioscapulohumeral muscular dystrophy families (FSHD) with 4q markers.
    Passos-Bueno MR; Wijmenga C; Takata RE; Marie SK; Vainzof M; Pavanello RC; Hewitt JE; Bakker E; Carvalho A; Akiyama J
    Hum Mol Genet; 1993 May; 2(5):557-62. PubMed ID: 8518794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy.
    Osborne RJ; Welle S; Venance SL; Thornton CA; Tawil R
    Neurology; 2007 Feb; 68(8):569-77. PubMed ID: 17151338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical phenotypes in patients with facioscapulohumeral muscular dystrophy 4q35 deletion.
    Krasnianski M; Eger K; Neudecker S; Jakubiczka S; Zierz S
    Arch Neurol; 2003 Oct; 60(10):1421-5. PubMed ID: 14568813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.